Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Coolex is a topical first-aid spray developed by Midas Care for the immediate treatment of minor burns and scalds. It functions as a physical cooling agent that rapidly lowers the temperature of the affected skin through evaporation, which helps to alleviate pain, reduce inflammation, and prevent the progression of thermal tissue damage. As an aerosol product, it allows for application without physical contact with the sensitive burn site, thereby minimizing the risk of contamination and further trauma. It is marketed as a non-toxic, non-irritant solution suitable for emergency burn care and is typically composed of purified water and propellants that facilitate the cooling effect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Coolex.